Showing results (191-200 of 425) with videos related to

Sort By:
Pageof 43
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1988
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonrespondersP Gresele, D Blockmans, H Deckmyn, et al.
American Journal of Obstetrics and Gynecology|October 18, 2000
Increase of the isoprostane 8-isoprostaglandin f2alpha in maternal and fetal blood of rats with streptozotocin-induced diabetes: evidence of lipid peroxidationR T Gerber, K Holemans, I O'Brien-Coker, et al.
American Journal of Medical Genetics|December 18, 2001
Associated malformations and chromosomal anomalies in 42 cases of prenatally diagnosed diaphragmatic herniaI Witters, E Legius, P Moerman, et al.
Acta Clinica Belgica|January 1, 1990
Protein C deficiency associated with venous thromboembolismW Wysokinski, R Verhaeghe, J Arnout, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1990
Pharmacological manipulation of the thromboxane pathway in blood plateletsB Hoet, H Deckmyn, J Arnout, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1976
Platelet-endotoxin interaction: a reviewN Semeraro, D Fumarola, P Telesforo, et al.
British Journal of Haematology|May 1, 1994
Optimization of the dilute prothrombin time for the detection of the lupus anticoagulant by use of a recombinant tissue thromboplastinJ Arnout, M Vanrusselt, E Huybrechts, et al.
Thrombosis and Haemostasis|November 15, 1993
Synergistic antiplatelet effect of ridogrel, a combined thromboxane receptor antagonist and thromboxane synthase inhibitor, and UDCG-212, a cAMP-phosphodiesterase inhibitorB Hoet, J Arnout, H Deckmyn, et al.
Thrombosis and Haemostasis|June 3, 1998
Monoclonal antibodies against beta-2-glycoprotein I: use as reference material for lupus anticoagulant testsJ Arnout, M Vanrusselt, C Wittevrongel, et al.
British Journal of Haematology|February 1, 1978
Evidence that endotoxins enhance the factor X activator activity of washed human plateletsN Semerraro, D Fumarola, F Mertens, et al.
Pageof 43